New Medicines of 2015
Dyanavel XR is a prescription drug used to treat Attention Deficit Hyperactivity Disorder (ADHD). Dyanavel XR belongs to a group of drugs called nervous system stimulants, which work by changing the amounts of certain chemicals in the brain. This medication is a solution taken once per day, either with or without food. Common side effects include dry mouth, decreased appetite, dizziness and weight loss. Do not drive or operate machinery until you know how Dyanavel XR affects you. Since Dyanavel XR is available as an oral suspension, it is a great ADHD option for children who cannot swallow pills or capsules. Plus, the oral suspension is extended-release meaning children only have to take it once a day.
Reviewed by:
Review Date:
December 29, 2015Citation:
U.S. Food and Drug Administration, "FDA approves first-of-its-kind product for the treatment of melanoma", 2015 U.S. Food and Drug Administration, "FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa", 2015 U.S. Food and Drug Administration, "FDA approves Ninlaro, new oral medication to treat multiple myeloma", 2015 U.S. Food and Drug Administration, "FDA approves new treatment for HIV", 2015 U.S. Food and Drug Administration, "FDA approves Nucala to treat severe asthma", 2015 U.S. Food and Drug Administration, "FDA approves new treatment for advanced pancreatic cancer", 2015 U.S. Food and Drug Administration, "FDA approves first treatment for sexual desire disorder", 2015 U.S. Food and Drug Administration, "FDA approves new drug to treat heart failure", 2015 U.S. Food and Drug Administration, "FDA approves Praluent to treat certain patients with high cholesterol", 2015 U.S. Food and Drug Administration, "FDA approves Corlanor to treat heart failure", 2015 All images appear courtesy of Dreamstime
Last Updated:
December 29, 2015